Plasma biomarkers of brain atrophy in Alzheimer's disease (Q28741028)

13

Hilkka Soininen

0 references

Lars-Olof Wahlund

7

Lars-Olof Wahlund

0 references

James Campbell

4

James Campbell

0 references

Anna Kinsey

Anna Kinsey

8

0 references

Richard Killick

Richard Killick

10

0 references

Eric Westman

Eric Westman

5

0 references

Simon Lovestone

Simon Lovestone

17

0 references

Patrizia Mecocci

Patrizia Mecocci

12

0 references

Bruno Vellas

15

Bruno Vellas

0 references

Magda N. Tsolaki

14

Magda Tsolaki

0 references

Madhav Thambisetty

1

Madhav Thambisetty

0 references

Abdul Hye

3

Abdul Hye

0 references

Mirsada Causevic

9

Mirsada Causevic

0 references

Christian Spenger

16

Christian Spenger

0 references

author name string

Andrew Simmons

2

0 references

Yi Zhang

Creative Commons CC0 License

6

0 references

language of work or name

English

0 references

publication date

2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

12

0 references

page(s)

e28527

0 references

copyright license

start time

21 December 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Biomarkers of cerebrovascular disease in dementia.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Disease-modifying therapies for Alzheimer disease: challenges to early intervention

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Proteome-based plasma biomarkers for Alzheimer's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Role of complement in neurodegeneration and neuroinflammation.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Yin and Yang: complement activation and regulation in Alzheimer’s disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Two-dimensional analysis of qualitative and quantitative changes in blood cell proteins in Alzheimer's disease: search for extraneuronal markers.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3244409

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028527

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22205954

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22205954